Skip to main content
. 2021 Nov 14;6(1):7–14. doi: 10.1016/j.jseint.2021.09.016

Table III.

Multivariate adjusted analysis of adverse event rates, early cohort (2005-2016) and late cohort (2017-2019).

Adverse event Early cohort
Late cohort
Inpatient Outpatient RR 95% CI P value Inpatient Outpatient RR 95% CI P value
Any complication 5.80% 1.98% 2.57 1.24-5.34 .011 3.90% 1.38% 2.30 1.39-3.80 .001
Specific complications
 Death 0.16% 0.28% 0.39 0.05-3.13 .372 0.15% 0.09% 1.31 0.17-10.12 .794
 Surgical site infection 0.45% 0.28% 2.08 0.28-15.61 .476 0.54% 0.26% 2.23 0.68-7.36 .188
 Wound dehiscence 0.06% 0.00% - - - 0.05% 0.00% - - -
 Pneumonia 0.50% 0.28% 1.32 0.18-9.74 .786 0.49% 0.09% 5.12 0.80-32.74 .085
 Deep vein thrombosis 0.35% 0.28% 1.14 0.14-9.04 .900 0.34% 0.09% 3.38 0.48-23.56 .219
 Pulmonary embolism 0.32% 0.28% 0.90 0.12-6.92 .917 0.27% 0.00% - - -
 Unexpected intubation 0.18% 0.00% - - - 0.23% 0.00% - - -
 Acute kidney injury 0.14% 0.00% - - - 0.15% 0.17% 0.64 0.14-2.98 .570
 Urinary tract infection 0.77% 0.28% 2.08 0.28-15.24 .472 0.20% 0.41% 0.71 0.34-1.46 .531
 Stroke 0.12% 0.00% - - - 0.08% 0.00% - - -
 Myocardial infarction 0.22% 0.00% - - - 0.27% 0.17% 1.63 0.41-6.52 .492
 Blood transfusion 3.34% 0.86% 3.34 1.09-10.28 .035 1.21% 0.00% - - -
 Sepsis 0.27% 0.00% - - - 0.15% 0.00% - - -
Return to the operating room 1.04% 0.28% 3.63 0.50-26.33 .202 1.44% 1.04% 1.37 0.74-2.53 .322
Readmission 2.79% 1.36% 1.85 0.69-4.96 .220 2.89% 1.82% 1.38 0.89-2.16 .146

RR, relative risk; CI, confidence interval.

Bold indicates statistical significance (P < .05).

Adjusted for each of the baseline characteristics listed in Table I.